The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Adaptive Biotechnologies Corporation(NASDAQ:ADPT) 
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ research service and kit that is used to answer translational research questions, as well as to discover new progno...
Website: http://www.adaptivebiotech.com
Founded: 2009
IPO Price: $20 (Jun 27, 2019)
Full Time Employees: 453
CEO: Chad Robins
Sector: Healthcare
Industry: Biotechnology
Adaptive Biotechnologies Days Payable Outstanding ttm (DPO)
Adaptive Biotechnologies Days Receivable Outstanding ttm (DSO)
Adaptive Biotechnologies Days Inventory Outstanding ttm (DIO)
Adaptive Biotechnologies Op Cashflow Per Share ttm
Adaptive Biotechnologies Free Cashflow Per Share ttm
Adaptive Biotechnologies Cash Per Share ttm
Adaptive Biotechnologies P/S ratio ttm
Adaptive Biotechnologies (GAAP) P/E ratio ttm
Adaptive Biotechnologies P/B ratio ttm
No extra charts and metrics for this ticker.